nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Cyclosporine—focal segmental glomerulosclerosis	0.602	0.782	CbGbCtD
Bosentan—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.106	0.138	CbGbCtD
Bosentan—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0618	0.0803	CbGbCtD
Bosentan—EDNRA—EGFR-dependent Endothelin signaling events—EDN1—focal segmental glomerulosclerosis	0.00756	0.0776	CbGpPWpGaD
Bosentan—Peripheral ischaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00561	0.0423	CcSEcCtD
Bosentan—Traumatic liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.0055	0.0414	CcSEcCtD
Bosentan—Nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.0324	CcSEcCtD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.00403	0.0414	CbGpPWpGaD
Bosentan—EDNRB—Endothelin Pathways—EDN1—focal segmental glomerulosclerosis	0.00374	0.0383	CbGpPWpGaD
Bosentan—EDNRB—Endothelins—TRPC6—focal segmental glomerulosclerosis	0.00344	0.0352	CbGpPWpGaD
Bosentan—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00337	0.0254	CcSEcCtD
Bosentan—EDNRB—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.003	0.0308	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.00289	0.0296	CbGpPWpGaD
Bosentan—EDNRB—Endothelins—GNAQ—focal segmental glomerulosclerosis	0.00287	0.0295	CbGpPWpGaD
Bosentan—EDNRA—Endothelin Pathways—EDN1—focal segmental glomerulosclerosis	0.00267	0.0274	CbGpPWpGaD
Bosentan—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.0198	CcSEcCtD
Bosentan—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.0197	CcSEcCtD
Bosentan—EDNRA—Endothelins—TRPC6—focal segmental glomerulosclerosis	0.00246	0.0252	CbGpPWpGaD
Bosentan—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.0183	CcSEcCtD
Bosentan—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.0178	CcSEcCtD
Bosentan—EDNRB—Peptide GPCRs—AGTR1—focal segmental glomerulosclerosis	0.00231	0.0237	CbGpPWpGaD
Bosentan—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.0171	CcSEcCtD
Bosentan—EDNRB—Endothelins—EDN1—focal segmental glomerulosclerosis	0.00223	0.0228	CbGpPWpGaD
Bosentan—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.0165	CcSEcCtD
Bosentan—EDNRA—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.00215	0.0221	CbGpPWpGaD
Bosentan—EDNRA—Endothelins—GNAQ—focal segmental glomerulosclerosis	0.00206	0.0211	CbGpPWpGaD
Bosentan—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.015	CcSEcCtD
Bosentan—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.0149	CcSEcCtD
Bosentan—ABCB11—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.00196	0.0201	CbGpPWpGaD
Bosentan—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.0146	CcSEcCtD
Bosentan—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.0128	CcSEcCtD
Bosentan—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.0126	CcSEcCtD
Bosentan—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.0125	CcSEcCtD
Bosentan—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.0125	CcSEcCtD
Bosentan—EDNRA—Peptide GPCRs—AGTR1—focal segmental glomerulosclerosis	0.00165	0.017	CbGpPWpGaD
Bosentan—EDNRA—Endothelins—EDN1—focal segmental glomerulosclerosis	0.00159	0.0163	CbGpPWpGaD
Bosentan—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.0118	CcSEcCtD
Bosentan—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.0115	CcSEcCtD
Bosentan—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.0115	CcSEcCtD
Bosentan—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.0114	CcSEcCtD
Bosentan—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.0111	CcSEcCtD
Bosentan—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.011	CcSEcCtD
Bosentan—EDNRB—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.00144	0.0148	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.00141	0.0145	CbGpPWpGaD
Bosentan—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.0106	CcSEcCtD
Bosentan—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.0103	CcSEcCtD
Bosentan—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.0102	CcSEcCtD
Bosentan—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.0101	CcSEcCtD
Bosentan—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00974	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.00129	0.0132	CbGpPWpGaD
Bosentan—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00952	CcSEcCtD
Bosentan—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00943	CcSEcCtD
Bosentan—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00931	CcSEcCtD
Bosentan—EDNRB—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.0012	0.0123	CbGpPWpGaD
Bosentan—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00905	CcSEcCtD
Bosentan—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.009	CcSEcCtD
Bosentan—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00894	CcSEcCtD
Bosentan—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00881	CcSEcCtD
Bosentan—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00876	CcSEcCtD
Bosentan—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00873	CcSEcCtD
Bosentan—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00868	CcSEcCtD
Bosentan—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00863	CcSEcCtD
Bosentan—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00863	CcSEcCtD
Bosentan—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00851	CcSEcCtD
Bosentan—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00848	CcSEcCtD
Bosentan—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00846	CcSEcCtD
Bosentan—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00841	CcSEcCtD
Bosentan—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00841	CcSEcCtD
Bosentan—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00839	CcSEcCtD
Bosentan—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00839	CcSEcCtD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00111	0.0113	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.0011	0.0113	CbGpPWpGaD
Bosentan—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00823	CcSEcCtD
Bosentan—EDNRB—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.00109	0.0111	CbGpPWpGaD
Bosentan—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00816	CcSEcCtD
Bosentan—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00814	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.00108	0.011	CbGpPWpGaD
Bosentan—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0081	CcSEcCtD
Bosentan—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00779	CcSEcCtD
Bosentan—EDNRA—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.00103	0.0106	CbGpPWpGaD
Bosentan—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00775	CcSEcCtD
Bosentan—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00775	CcSEcCtD
Bosentan—ABCB11—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.00102	0.0105	CbGpPWpGaD
Bosentan—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00771	CcSEcCtD
Bosentan—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00765	CcSEcCtD
Bosentan—EDNRA—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.00101	0.0104	CbGpPWpGaD
Bosentan—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00759	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.000984	0.0101	CbGpPWpGaD
Bosentan—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000959	0.00722	CcSEcCtD
Bosentan—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000954	0.00719	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000948	0.00972	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.000933	0.00957	CbGpPWpGaD
Bosentan—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000933	0.00703	CcSEcCtD
Bosentan—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000927	0.00698	CcSEcCtD
Bosentan—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000923	0.00695	CcSEcCtD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.000921	0.00945	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.000921	0.00945	CbGpPWpGaD
Bosentan—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000901	0.00679	CcSEcCtD
Bosentan—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000895	0.00674	CcSEcCtD
Bosentan—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000882	0.00665	CcSEcCtD
Bosentan—EDNRA—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.000861	0.00883	CbGpPWpGaD
Bosentan—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000861	0.00648	CcSEcCtD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000851	0.00872	CbGpPWpGaD
Bosentan—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000844	0.00636	CcSEcCtD
Bosentan—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000839	0.00632	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.000835	0.00856	CbGpPWpGaD
Bosentan—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000827	0.00623	CcSEcCtD
Bosentan—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000818	0.00616	CcSEcCtD
Bosentan—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000804	0.00606	CcSEcCtD
Bosentan—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000801	0.00604	CcSEcCtD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000792	0.00812	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.000788	0.00808	CbGpPWpGaD
Bosentan—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000781	0.00589	CcSEcCtD
Bosentan—EDNRA—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.000778	0.00797	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.000774	0.00794	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.00077	0.0079	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.000765	0.00784	CbGpPWpGaD
Bosentan—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000762	0.00574	CcSEcCtD
Bosentan—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000762	0.00574	CcSEcCtD
Bosentan—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000759	0.00572	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000757	0.0057	CcSEcCtD
Bosentan—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000753	0.00567	CcSEcCtD
Bosentan—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000745	0.00562	CcSEcCtD
Bosentan—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00073	0.0055	CcSEcCtD
Bosentan—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00073	0.0055	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000729	0.00747	CbGpPWpGaD
Bosentan—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000726	0.00547	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000722	0.0074	CbGpPWpGaD
Bosentan—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000716	0.0054	CcSEcCtD
Bosentan—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000715	0.00539	CcSEcCtD
Bosentan—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00071	0.00535	CcSEcCtD
Bosentan—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000706	0.00532	CcSEcCtD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.000705	0.00722	CbGpPWpGaD
Bosentan—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000696	0.00525	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000693	0.0071	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000678	0.00696	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.000668	0.00685	CbGpPWpGaD
Bosentan—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000666	0.00501	CcSEcCtD
Bosentan—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000661	0.00498	CcSEcCtD
Bosentan—EDNRA—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.000659	0.00676	CbGpPWpGaD
Bosentan—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000656	0.00494	CcSEcCtD
Bosentan—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000651	0.00491	CcSEcCtD
Bosentan—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000649	0.00489	CcSEcCtD
Bosentan—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000643	0.00485	CcSEcCtD
Bosentan—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000635	0.00478	CcSEcCtD
Bosentan—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000631	0.00475	CcSEcCtD
Bosentan—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00063	0.00475	CcSEcCtD
Bosentan—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000625	0.00471	CcSEcCtD
Bosentan—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000625	0.00471	CcSEcCtD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000618	0.00634	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000609	0.00624	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000597	0.0045	CcSEcCtD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.000597	0.00612	CbGpPWpGaD
Bosentan—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00058	0.00437	CcSEcCtD
Bosentan—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000577	0.00435	CcSEcCtD
Bosentan—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000577	0.00435	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000555	0.00569	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.000554	0.00568	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.000547	0.00561	CbGpPWpGaD
Bosentan—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000538	0.00406	CcSEcCtD
Bosentan—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000524	0.00395	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000522	0.00535	CbGpPWpGaD
Bosentan—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000517	0.00389	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000517	0.0053	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000513	0.00526	CbGpPWpGaD
Bosentan—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0005	0.00377	CcSEcCtD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000496	0.00508	CbGpPWpGaD
Bosentan—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000483	0.00364	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000471	0.00482	CbGpPWpGaD
Bosentan—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000464	0.0035	CcSEcCtD
Bosentan—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000461	0.00347	CcSEcCtD
Bosentan—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00046	0.00347	CcSEcCtD
Bosentan—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000458	0.00345	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000442	0.00453	CbGpPWpGaD
Bosentan—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000434	0.00327	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00041	0.00421	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000408	0.00418	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000397	0.00407	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000391	0.004	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000385	0.00395	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000373	0.00382	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00037	0.0038	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000367	0.00376	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000354	0.00363	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000343	0.00352	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000337	0.00345	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000314	0.00322	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000311	0.00319	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000299	0.00307	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000294	0.00301	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000292	0.00299	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000285	0.00292	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000281	0.00288	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00028	0.00287	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000276	0.00283	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000267	0.00273	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000266	0.00273	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000265	0.00272	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000254	0.0026	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000247	0.00254	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000245	0.00252	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000241	0.00248	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000225	0.0023	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000223	0.00229	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000221	0.00226	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00022	0.00226	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000219	0.00224	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000214	0.0022	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000204	0.00209	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.0002	0.00206	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00019	0.00195	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000184	0.00189	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000173	0.00177	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000171	0.00176	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000168	0.00173	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000158	0.00162	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000158	0.00162	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000157	0.00161	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000147	0.0015	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000143	0.00147	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000143	0.00146	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000138	0.00142	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000132	0.00135	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000131	0.00134	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000125	0.00128	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00012	0.00123	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000118	0.00121	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000113	0.00115	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00011	0.00113	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000109	0.00112	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000102	0.00105	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000101	0.00104	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.91e-05	0.00102	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.38e-05	0.000962	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	9.38e-05	0.000962	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.1e-05	0.000933	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.47e-05	0.000869	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	8.26e-05	0.000847	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.83e-05	0.000803	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—LPL—focal segmental glomerulosclerosis	7.63e-05	0.000783	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.97e-05	0.000715	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AGT—focal segmental glomerulosclerosis	6.53e-05	0.00067	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.52e-05	0.000668	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.75e-05	0.000589	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.72e-05	0.000587	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—focal segmental glomerulosclerosis	5.01e-05	0.000514	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.99e-05	0.000512	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.9e-05	0.000502	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	4.18e-05	0.000428	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.11e-05	0.000422	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.76e-05	0.000385	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	3.68e-05	0.000377	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.39e-05	0.000347	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	2.75e-05	0.000282	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	2.55e-05	0.000261	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	2.43e-05	0.000249	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.23e-05	0.000229	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	2.18e-05	0.000224	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.68e-05	0.000172	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.67e-05	0.000172	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1.44e-05	0.000147	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.1e-05	0.000113	CbGpPWpGaD
